China Health Technology Group Holding Co (OTCPK:CHBOF) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
China Health Technology Group Holding Co Cash Conversion Cycle Related Terms
China Health Technology Group Holding Co Cash Conversion Cycle Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Technology Group Holding Co Cash Conversion Cycle Chart
China Health Technology Group Holding Co Annual Data
CHBOF vs SSD, UFPI, BCC: Cash Conversion Cycle Comparison
For the Lumber & Wood Production subindustry, China Health Technology Group Holding Co's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Health Technology Group Holding Co Cash Conversion Cycle vs Forest Products Industry
For the Forest Products industry and Basic Materials sector, China Health Technology Group Holding Co's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where China Health Technology Group Holding Co's Cash Conversion Cycle falls into.
China Health Technology Group Holding Co Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Technology Group Holding Co (CHBOF) has a Cash Conversion Cycle of 151.34 as of Dec. 2025. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on China Health Technology Group Holding Co and its competitors.
Is China Health Technology Group Holding Co's Cash Conversion Cycle too high?
China Health Technology Group Holding Co's current Cash Conversion Cycle is 151.34. The Forest Products industry median Cash Conversion Cycle is 91.34. China Health Technology Group Holding Co's value of 151.34 is 65.7% above this industry median. Overall, China Health Technology Group Holding Co has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does China Health Technology Group Holding Co's Cash Conversion Cycle compare to SSD and UFPI?
China Health Technology Group Holding Co's Cash Conversion Cycle of 151.34 can be compared against companies in the Forest Products industry. The industry median Cash Conversion Cycle is 91.34. China Health Technology Group Holding Co's value of 151.34 is 65.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Forest Products company?
The median Cash Conversion Cycle among Forest Products companies is 91.34, based on 283 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Health Technology Group Holding Co's current Cash Conversion Cycle of 151.34 is 65.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on China Health Technology Group Holding Co and its competitors. For the Forest Products industry, the median Cash Conversion Cycle is 91.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Health Technology Group Holding Co's current Cash Conversion Cycle is 151.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Technology Group Holding Co stock overvalued right now?
China Health Technology Group Holding Co (CHBOF) has a current Cash Conversion Cycle of 151.34. The stock's GF Value™ is $0.07, compared to a current price of $0.03 — trading 52.9% below its estimated fair value. The current Cash Conversion Cycle is 151.34 and 65.7% above the Forest Products industry median of 91.34. China Health Technology Group Holding Co's overall GF Score™ is 25/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For China Health Technology Group Holding Co (CHBOF), the current Cash Conversion Cycle is 151.34 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Health Technology Group Holding Co (CHBOF) Overvalued in 2026?
Based on GuruFocus' analysis, China Health Technology Group Holding Co stock appears to be undervalued.
The current stock price of $0.03 is trading 52.9% below its estimated GF Value™ of $0.07.
Key valuation signals for CHBOF:
Cash Conversion Cycle: 151.34
GF Value™: $0.07 vs. price of $0.03 (52.9% below fair value)
Industry Position: 65.7% above the Forest Products median
No single metric tells the full story. See the CHBOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Health Technology Group Holding Co Business Description
China Health Technology Group Holding Co Ltd is an investment holding company. It is engaged in the business of management of new agriculture and forestry resources in the People's Republic of China. The company has reportable segments including the Forestry business; Horny Goat Weed Business; Health products business and Ginseng Business. The forestry management business includes plantation, logging, and sale of timber-related products and the Ginseng Business includes ginseng plantation and trading of related products. The company generates a majority of its revenue from the Forestry business segment. Geographically company generates its key revenue from the PRC.
25GF Score
Get the complete analysis for CHBOF
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHBOF has been successfully added to your 
